Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer Group.

Source:http://linkedlifedata.com/resource/pubmed/id/12481889

Download in:

View as

General Info

PMID
12481889